Welcome to WFIPP.org

World Federation of Incontinence and Pelvic Problems

For people living with incontinence and pelvic floor dysfunction.

Highlighted

Commitment to Collaboration in Continence Care (4Cs) – Executive Summary

The Commitment to Collaboration in Continence Care (4Cs) multistakeholder group met in Valencia on 10 November 2023. The meeting objectives were to: a) review progress made in 2023, and b) agree priorities for 2024, aligned with the 4Cs objectives. Discussion focused on maintaining momentum from the 1st EU Continence Health Summit “An Urge to Act”, which was held on 8 November in Brussels, Belgium.

 Read more

Manifesto for policy reform on Continence Health in Europe

On 8 November the EAU joined 22 scientific, professional, patient and non-profit organizations in launching a manifesto for policy reform on Continence Health in Europe. The manifesto was launched at the first Continence Health Summit in Brussels and aims to raise awareness among EU and national policymakers of continence health problems and to instill the need for action.

 Read more

32nd National Conference on Incontinence 2024 15 – 18 May 2024 Brisbane Convention & Exhibition Centre

May 15 2024 - May 18 2024

NCOI 2024 is Australia’s premier multidisciplinary meeting for health professionals working in bladder, bowel and pelvic floor health. The conference brings together some of the sector’s most influential decision-makers to showcase the latest in incontinence research and practice, presented in a broad range of sessions and workshops.

 Read more

Versameb AG Announces FDA Clearance of IND Application for VMB-100 in the Treatment of Stress Urinary Incontinence

BASEL, Switzerland, Nov. 16, 2023: Versameb AG (“Versameb”), a pre-clinical stage company focused on  transforming RNA therapeutics to treat unmet medical needs, today announced that the U.S. Food and  Drug Administration (FDA) has cleared its Investigational New Drug (IND) application of VMB-100, a potency enhanced messenger ribonucleic acid (mRNA) encoding human insulin-like growth factor-1 (IGF […]

 Read more

Recording of UROwebinar – “(Data-driven) Shared Decision-making (SDM) in the management of incontinence”

Did you miss Tuesday’s webinar on (Data-driven) Shared Decision-making in the management of Incontinence? No Problem. You can watch the live recording or complete the e-course here.  

 Read more

EAU24 – Paris

April 5 2024 - April 8 2024

Registration has now opened for the 39th Annual EAU Congress in Paris! EAU24 will take place in the French capital on 5-8 April 2024. The lowest-priced Early Registration Fees are now available, with different rates for EAU Members and non-members, for Junior Members, Researchers, patient advocates and more.

 Read more

EAU24 Paris – Awards

April 5 2024 - April 8 2024

Your moment to shine is here! If you would like to be considered for one of the prestigious EAU Awards, applications are now open

 Read more

PRESS RELEASE: Alarmingly Low Awareness of Urology Across Europe

The EAU will again conduct an international survey to assess the general knowledge on urology. We have asked over 3,000 members of the public from the United Kingdom, France, Germany, Italy, and the Netherlands 10 questions on the topic of Incontinence. If you are interested in conducting a similar survey yourself at a local or national level, we would be happy to send you the survey questions for translation.

 Read more

New Corporate Partner Astellas Pharma Inc.

WFIPP welcomes our new Corporate Partner Astellas Pharma Inc. Astellas Pharma Inc. is a pharmaceutical company conducting business in more than 70 countries around the world. We are promoting the Focus Area Approach that is designed to identify opportunities for the continuous creation of new drugs to address diseases with high unmet medical needs by […]

 Read more

New Corporate Partner Amara Therapeutics

WFIPP welcomes our new Corporate Partner Amara Therapeutics. Amara Therapeutics is an Irish-based Digital Therapeutics company who develop app-based treatments for patients suffering from Overactive Bladder (OAB). The company is a spin out from the University of Galway in Ireland and their mission is to make clinically proven, guideline recommended, behavioural therapy available to all […]

 Read more

Joint proposal EAU/ICS/WFIPP to the European Commission regarding mental health and incontinence

WFIPP has joined forces with the EAU (Patient Advocacy group EPAG of which WFIPP is a member) and the ICS to highlight the bi-directional relationship between mental health and incontinence. Mental health problems can trigger incontinence, and the difficulties faced by people living with incontinence and their loved ones can lead to stigmatization, stress and […]

 Read more

Digital platform

Support In Continence

The platform which is intended to act as a helpful resource for all stakeholders, patients, families, carers, HCPs and institutions who are in some way involved in the patient pathway relating to incontinence

Support In Continence Platform New updates

Latest news

View all posts

Versameb AG Announces FDA Clearance of IND Application for VMB-100 in the Treatment of Stress Urinary Incontinence

BASEL, Switzerland, Nov. 16, 2023: Versameb AG (“Versameb”), a pre-clinical stage company focused on  transforming RNA therapeutics to treat unmet medical needs, today announced that the U.S. Food and  Drug Administration (FDA) has cleared its Investigational New Drug (IND) application of VMB-100, a potency enhanced messenger ribonucleic acid (mRNA) encoding human insulin-like growth factor-1 (IGF […]

 Read more

BULKAMID – It’s time to say goodbye to Bladder Leaks

If you struggle with bladder leaks during normal daily activities like coughing, sneezing, or during physical activity, you may be a candidate for Bulkamid.
Bulkamid is a minimally invasive and long-lasting treatment option for bladder leaks caused by Stress Urinary Incontinence (SUI).
When given the choice of treatment options for SUI, the majority of women choose Bulkamid.

 Read more

Commitment to Collaboration in Continence Care (4Cs) – Executive Summary

The Commitment to Collaboration in Continence Care (4Cs) multistakeholder group met in Valencia on 10 November 2023. The meeting objectives were to: a) review progress made in 2023, and b) agree priorities for 2024, aligned with the 4Cs objectives. Discussion focused on maintaining momentum from the 1st EU Continence Health Summit “An Urge to Act”, which was held on 8 November in Brussels, Belgium.

 Read more

MANIFESTO | European Institute for Women’s Health Manifesto for Women’s Health

The European Institute for Women’s Health issued its 2024 EU Manifesto for Women’s Health! The document outlines the need for action on women’s health and provides key facts and figures on the current state of play for women in the EU. It describes the key priorities for improving the health and wellbeing of women across the […]

 Read more